Global Biopharmaceuticals Contract Manufacturing Market

Biopharmaceuticals Contract Manufacturing Market Size, Share, Growth Analysis, By Service (Manufacturing, Formulation & Fill-Finish), By Type (Biologic Drug Substance Manufacturing, Biologic Drug Product Manufacturing), By Scale Of Operation, By Source, By Molecule Type, By Region - Industry Forecast 2026-2033

Report ID: SQSG35H2019 | Region: Global | Published Date: November, 2025
Pages: 157 |Tables: 120 |Figures: 77

To request a free sample copy of this report, please complete the form below.

Our Clients

  • Schineder Electric
  • KSIA - Korea Semiconductor Industry Association
  • Hitachi Astemo Limited
  • Samsung Electronics
  • Halvo holdings
  • NTT corporation
  • AGC Inc
  • Siemens AG
  • Unilever
  • Merck Pharmaceuticals
  • Atlas Copco
  • Hologic - Medical Technology company
  • Novartis
  • Henkel
  • Reckitt
  • Schineder Electric
  • KSIA - Korea Semiconductor Industry Association
  • Hitachi Astemo Limited
  • Samsung Electronics
  • Halvo holdings
  • NTT corporation
  • AGC Inc
  • Siemens AG
  • Unilever
  • Merck Pharmaceuticals
  • Atlas Copco
  • Hologic - Medical Technology company
  • Novartis
  • Henkel
  • Reckitt

    • FAQs

    Global Biopharmaceuticals Contract Manufacturing Market size was valued at USD 17.85 Billion in 2024 and is poised to grow from USD 19.32 Billion in 2025 to USD 36.29 Billion by 2033, growing at a CAGR of 8.2% during the forecast period (2026–2033).

    Global biopharmaceuticals contract manufacturing market is consolidated in nature with the presence of several large market players operating across the globe. And, in terms of market share, top 5 players of the market are dominating the market including Boehringer Ingelheim, JSR Pharma, and Inno Biologics Sdn Bhd. These players are highly focusing on few business developing strategies including collaborations, mergers, new product innovations, and advance technology adoption to expand their geographical presence and product offerings. 'Lonza (Switzerland) ', 'Thermo Fisher Scientific Inc. (US) ', 'WuXi Biologics (China) ', 'Catalent, Inc. (US) ', 'Samsung Biologics (South Korea) ', 'Boehringer Ingelheim International GmbH (Germany) ', 'Fujifilm Holdings Corporation (Japan) ', 'AbbVie Inc. (US) ', 'Eurofins Scientific (Luxembourg) ', 'GenScript Biotech Corporation (China) ', 'AGC Inc. (Japan) ', 'Merck ', 'KGaA (Germany) ', 'JSR Corporation (Japan) ', 'Stelis (India) ', 'Recipharm AB (Sweden) ', 'Emergent (US) ', 'Shanghai Fosun Pharmaceutical Co., Ltd. (China) ', 'Lotte Biologics (South Korea) ', 'Hepalink Group (China) ', 'Curia Global, Inc. (US)'

    Continuously rising generics demand, rising research & developments activities, and growing investments in advanced technologies are major factors expected to drive the growth of the global biopharmaceuticals market over the forecast period. Moreover, increasing demand for biological therapies and expansion in nuclear medicine sector coupled with the higher emphasis on specialty medicines are some others factors projected to have a positive impact on the global market over the coming years.

    Introduction of AI Boosting Biopharmaceuticals Contract Manufacturing Market Growth: In the last few years, the biopharmaceutical contract manufacturing market has grown significantly owing to the growth in the scientific curiosity in various medical areas in which researchers have been searching and improving cure for fatal diseases. Additionally, increasing popularity of advanced artificial intelligence to analyze patient’s symptoms and help to track other people also with similar symptoms, is likely to create lucrative growth opportunities for the global market over the coming years.

    Globally, North America region dominated the biopharmaceuticals contract manufacturing with a holding of strong market share in 2021 due to the large number of biomanufacturing facilities in the United States. Additionally, interventions & conferences conducted in the North America for pertinent developing technologies and major issues in applications of biologics for the better treatment of several chronic disorders are likely to fuel the adoption of contract manufacturing services in the region over the coming years.

    Related Reports

    Pharmaceutical Contract Manufacturing Market
    Buy Now GET FREE SAMPLE
    Pharmaceutical Contract Development and Manufacturing Market
    Buy Now GET FREE SAMPLE
    Medical Device Contract Manufacturing Market
    Buy Now GET FREE SAMPLE
    Pharmaceutical Manufacturing Market
    Buy Now GET FREE SAMPLE
    Food Contract Manufacturing Market
    Buy Now GET FREE SAMPLE
    Plastic Contract Manufacturing Market
    Buy Now GET FREE SAMPLE
    Pharmaceutical Logistics Market
    Buy Now GET FREE SAMPLE
    Biopharmaceuticals Third Party Logistics 3pl Market
    Buy Now GET FREE SAMPLE

    Feedback From Our Clients

    Global Biopharmaceuticals Contract Manufacturing Market

    Report ID: SQSG35H2019

    $5,300
    BUY NOW